Narcotic antagonists in the treatment of opiate dependence.
D000498:Allyl Compounds / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use; D003496:Cyclazocine / Q000008:administration & dosage / Q000627:therapeutic use; D004988:Ethers, Cyclic / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D009019:Morphinans / Q000627:therapeutic use; D009021:Morphine Dependence / Q000188:drug therapy*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome; D013997:Time Factors; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000498:Allyl Compounds; D002219:Carbamates; D004988:Ethers, Cyclic; D009019:Morphinans; D009292:Narcotic Antagonists; D014149:Tranquilizing Agents; D003496:Cyclazocine; D008691:Methadone